Home/Filings/4/0000950170-25-094011
4//SEC Filing

Lamy Patrick 4

Accession 0000950170-25-094011

CIK 0001744659other

Filed

Jul 2, 8:00 PM ET

Accepted

Jul 3, 6:00 PM ET

Size

4.7 KB

Accession

0000950170-25-094011

Insider Transaction Report

Form 4
Period: 2025-07-01
Lamy Patrick
Senior VP, Commercial Strategy
Transactions
  • Sale

    Common Stock

    2025-07-01$52.88/sh2,000$105,76029,891 total
Footnotes (1)
  • [F1]The reported transactions were effected pursuant to a Rule 10b5-1 trading plan dated January 6, 2025, previously adopted by the Reporting Person.

Documents

1 file

Issuer

Akero Therapeutics, Inc.

CIK 0001744659

Entity typeother

Related Parties

1
  • filerCIK 0001961273

Filing Metadata

Form type
4
Filed
Jul 2, 8:00 PM ET
Accepted
Jul 3, 6:00 PM ET
Size
4.7 KB